Literature DB >> 20458039

Brain tumors: from childhood through adolescence into adulthood.

Mark W Kieran1, David Walker, Didier Frappaz, Michael Prados.   

Abstract

The transition from childhood to adulthood through adolescence has been clearly identified as a time of great physical, psychological, emotional, social, and sexual change. Clinical care is currently divided into adult or pediatric care; adolescent patients require specific expertise that most clinical practices do not have. When illness coincides with the adolescent transition, the health system is severely challenged. Health systems historically have varied widely in the age they choose for allocating an individual to the adult model of health care. Tumors of the CNS complicate the difficult adjustments required in adolescents and young adults by virtue of their morbidity, complex treatment, and prognosis. Some brain tumors are unique to children, some occur predominantly in adults, and others peak in adolescence. Delays in the diagnosis of brain tumors can occur at any age but are particularly common in adolescence because of difficulties of accessing health systems, the difficulties of discriminating pathologic from typical adolescent behavioral characteristics, and changing endocrine function. Coming to terms with the cancer diagnosis; coping personally, socially, and financially with cancer treatments; accepting the risk of a shortened life span; confronting acquired disability; and coping with complex rehabilitation and adjusted plans for life are challenges for which there are no established specialist health models. This article will discuss the changing brain tumor profile of children, adolescents, and adults, with a focus on our limited understanding of the adolescent/young adult transition period.

Entities:  

Mesh:

Year:  2010        PMID: 20458039     DOI: 10.1200/JCO.2010.28.3481

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  31 in total

1.  "Groans less, seems more comfortable:" Harvey Cushing's redefinition of success in the operative treatment of pediatric intracranial lesions.

Authors:  Courtney Pendleton; George I Jallo; Aaron A Cohen-Gadol; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2010-10-27       Impact factor: 1.475

2.  Harvey Cushing and pediatric brain tumors at Johns Hopkins: the early stages of development.

Authors:  Courtney Pendleton; Edward S Ahn; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg Pediatr       Date:  2011-06       Impact factor: 2.375

3.  Freiburg neuropathology case conference: a mass lesion of the mesial temporal lobe in a child.

Authors:  C A Taschner; O Staszewski; J Zentner; S Meckel; M Prinz
Journal:  Clin Neuroradiol       Date:  2011-09       Impact factor: 3.649

4.  Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors.

Authors:  Jacquelyn J Roth; Mariarita Santi; Lucy B Rorke-Adams; Brian N Harding; Tracy M Busse; Laura S Tooke; Jaclyn A Biegel
Journal:  Cancer Genet       Date:  2014-03-15

5.  Family factors associated with academic achievement deficits in pediatric brain tumor survivors.

Authors:  Emily Ach; Cynthia A Gerhardt; Maru Barrera; Mary Jo Kupst; Eugene A Meyer; Andrea F Patenaude; Kathryn Vannatta
Journal:  Psychooncology       Date:  2012-10-12       Impact factor: 3.894

6.  Delayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions.

Authors:  Aska Arnautovic; Catherine Billups; Alberto Broniscer; Amar Gajjar; Frederick Boop; Ibrahim Qaddoumi
Journal:  Childs Nerv Syst       Date:  2015-03-06       Impact factor: 1.475

Review 7.  In vivo bio-imaging using chlorotoxin-based conjugates.

Authors:  Mark R Stroud; Stacey J Hansen; James M Olson
Journal:  Curr Pharm Des       Date:  2011-12       Impact factor: 3.116

8.  Ventromorphins: A New Class of Small Molecule Activators of the Canonical BMP Signaling Pathway.

Authors:  Jamie R Genthe; Jaeki Min; Dana M Farmer; Anang A Shelat; Jose A Grenet; Wenwei Lin; David Finkelstein; Karen Vrijens; Taosheng Chen; R Kiplin Guy; Wilson K Clements; Martine F Roussel
Journal:  ACS Chem Biol       Date:  2017-08-29       Impact factor: 5.100

Review 9.  Misactivation of Hedgehog signaling causes inherited and sporadic cancers.

Authors:  David R Raleigh; Jeremy F Reiter
Journal:  J Clin Invest       Date:  2019-02-01       Impact factor: 14.808

Review 10.  Extracellular Vesicles in Brain Tumor Progression.

Authors:  Esterina D'Asti; Shilpa Chennakrishnaiah; Tae Hoon Lee; Janusz Rak
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.